SPROのPER（株価収益率）は？

Spero Therapeutics Inc（SPRO）は現在PER 2.15倍で取引されています。

SPROのROE（自己資本利益率）は？

Spero Therapeutics IncのROEは28.78%です。

SPROの配当利回りは？

Spero Therapeutics Incの配当利回りは0.00%です。

SPROの品質スコア（Quality Score）は？

当社のAIはSPROの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

SPROは今が買い時ですか？

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

SPROはどのセクターに属しますか？

Spero Therapeutics IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

SPRO (NASDAQ) 株価分析 | SPERO THERAPEUTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

SPRO AI Analysis Summary

Our AI summary for SPRO: Spero Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 2.15, ROE of 28.78%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SPRO

Spero Therapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 1.15

-0.02 (-1.71%) Day Change

Watchlist Portfolio Compare Chart

2.15

P/E

0.04

D/E

28.8%

ROE

25.8%

ROA

0.00%

Div Yield

-0.01

PEG

SPERO THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.15 Price -0.02 (-1.71%) Day Change	NEWS SCORE: 89

SPRO, ファンダメンタルスコアはok ( ファンダメンタル = 62) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

58%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	107
Magic Formula Rank by ROE	107
Magic Formula Rank by ROIC	35 GREAT
Price	1.15
PBV / Sector	1.28 / 44,219.29 GOOD
Earning Per Share	0.26

PE / Sector	2.15 / 19.28 GREAT
PEG or PE/Growth / Sector	-0.01 / 1.23
Average 1M Daily Value	3.34 M GREAT
Average 1W Daily Value	1.26 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	27.82 / 98.22 GREAT
NPM Average (%) / Sector	-34.86 / -1,697.63
NPM Change Average (%) / Sector	-222.48 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	25.81 / 185,260.96 GREAT
ROA Average (%) / Sector	-9.69 / 36,684.70
ROA Change Average (%) / Sector	-185.55 / 422,221.66
ROE (%) / Sector	28.78 / 243,762.23 GOOD
ROE Average (%) / Sector	-29.03 / 48,758.47
ROE Change Average (%) / Sector	-235.82 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:02:11
Symbol	SPRO
Name	SPERO THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	57.90 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	67.74 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139

Phone: 857 242 1600

Website: https://sperotherapeutics.com

Sector: Healthcare >> Biotechnology

Description: Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, manufacture, and commercialize tebipenem pivoxil and tebipenem HBr; and Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries. Spero Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.